IONS — IONIS PHARMACEUTICALS INC

Ownership history in EntryPoint Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in IONIS PHARMACEUTICALS INC (IONS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.09% (2024 Q4)
Avg. % of fund
0.06%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 3,458 -2,924 -45.8% 0.09% $226K $65.42
2024 Q4 ADDED 6,382 +6,306 +8297.4% 0.09% $223K $34.96
2024 Q1 REDUCED 76 -802 -91.3% 0.00% $3K $43.35
2023 Q4 INITIATED 878 — — 0.04% $44K —
% of Fund (quarterly)    IONS price (monthly, adj. close)

Other funds also holding IONS

As of 2025 Q4 — sorted by position size

Tweedy, Browne Co LLC 3Y 7Y 15.74% BOONE CAPITAL MANAGEMENT LLC 3Y 10.37% Bellevue Group AG 3Y 7Y 7.2% Tri Locum Partners LP 3Y 5.72% Orion Investment Co 5.43% Exome Asset Management LLC 4.41% Privium Fund Management B.V. 3Y 3.51% Sicart Associates LLC 3Y 7Y 3.43% SECTOR GAMMA AS 3Y 7Y 3.34% SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3Y 7Y 2.41%
← Back to EntryPoint Capital, LLC Holdings